Celldex Therapeutics | CLDX - Market Capitalization

Stock Price
29.26
Daily Change
0.72 2.52%
Monthly
27.11%
Yearly
47.18%
Q1 Forecast
28.62

Celldex Therapeutics reported $1.87B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 1.66B 1.55B Mar/2026
Amgen USD 176.25B 24.32B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Glaxosmithkline GBP 86.88B 7.29B Sep/2025
Pfizer USD 153.96B 12.4B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025